Lemckert A[Author] - Search Results

Year	Number of Results
2001	4
2002	1
2003	2
2004	4
2005	4
2006	6
2007	1
2008	1
2009	1
2010	1
2014	1
2015	1
2016	1
2017	1
2018	2
2021	3
2024	0

1

Developing a manufacturing process to deliver a cost effective and stable liquid human rotavirus vaccine.

Hamidi A, Hoeksema F, Velthof P, Lemckert A, Gillissen G, Luitjens A, Bines JE, Pullagurla SR, Kumar P, Volkin DB, Joshi SB, Havenga M, Bakker WAM, Yallop C. Hamidi A, et al. Among authors: lemckert a. Vaccine. 2021 Apr 8;39(15):2048-2059. doi: 10.1016/j.vaccine.2021.03.033. Epub 2021 Mar 18. Vaccine. 2021. PMID: 33744044 Free PMC article.

2

Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5-based Constructs.

Alonso-Padilla J, Papp T, Kaján GL, Benkő M, Havenga M, Lemckert A, Harrach B, Baker AH. Alonso-Padilla J, et al. Among authors: lemckert a. Mol Ther. 2016 Feb;24(1):6-16. doi: 10.1038/mt.2015.194. Epub 2015 Oct 19. Mol Ther. 2016. PMID: 26478249 Free PMC article. Review.

3

Human AdV-20-42-42, a Promising Novel Adenoviral Vector for Gene Therapy and Vaccine Product Development.

Ballmann MZ, Raus S, Engelhart R, Kaján GL, Beqqali A, Hadoke PWF, van der Zalm C, Papp T, John L, Khan S, Boedhoe S, Danskog K, Frängsmyr L, Custers J, Bakker WAM, van der Schaar HM, Arnberg N, Lemckert AAC, Havenga M, Baker AH. Ballmann MZ, et al. Among authors: lemckert aac. J Virol. 2021 Oct 27;95(22):e0038721. doi: 10.1128/JVI.00387-21. Epub 2021 Sep 1. J Virol. 2021. PMID: 34469243 Free PMC article.

4

Heterologous prime-boost vaccinations for poverty-related diseases: advantages and future prospects.

Radosević K, Rodriguez A, Lemckert A, Goudsmit J. Radosević K, et al. Among authors: lemckert a. Expert Rev Vaccines. 2009 May;8(5):577-92. doi: 10.1586/erv.09.14. Expert Rev Vaccines. 2009. PMID: 19397415 Review.

5

Challenges in manufacturing adenoviral vectors for global vaccine product deployment.

Vellinga J, Smith JP, Lipiec A, Majhen D, Lemckert A, van Ooij M, Ives P, Yallop C, Custers J, Havenga M. Vellinga J, et al. Among authors: lemckert a. Hum Gene Ther. 2014 Apr;25(4):318-27. doi: 10.1089/hum.2014.007. Epub 2014 Apr 2. Hum Gene Ther. 2014. PMID: 24593243 Review.

6

Human species D adenovirus hexon capsid protein mediates cell entry through a direct interaction with CD46.

Persson BD, John L, Rafie K, Strebl M, Frängsmyr L, Ballmann MZ, Mindler K, Havenga M, Lemckert A, Stehle T, Carlson LA, Arnberg N. Persson BD, et al. Among authors: lemckert a. Proc Natl Acad Sci U S A. 2021 Jan 19;118(3):e2020732118. doi: 10.1073/pnas.2020732118. Proc Natl Acad Sci U S A. 2021. PMID: 33384338 Free PMC article.

7

Enhancing viral vaccine production using engineered knockout vero cell lines - A second look.

Hoeksema F, Karpilow J, Luitjens A, Lagerwerf F, Havenga M, Groothuizen M, Gillissen G, Lemckert AAC, Jiang B, Tripp RA, Yallop C. Hoeksema F, et al. Among authors: lemckert aac. Vaccine. 2018 Apr 12;36(16):2093-2103. doi: 10.1016/j.vaccine.2018.03.010. Epub 2018 Mar 16. Vaccine. 2018. PMID: 29555218 Free PMC article.

8

Challenges in the search for an HIV vaccine.

Lemckert AA, Goudsmit J, Barouch DH. Lemckert AA, et al. Eur J Epidemiol. 2004;19(6):513-6. doi: 10.1023/b:ejep.0000032423.87658.68. Eur J Epidemiol. 2004. PMID: 15330122 Review.

9

Generation and characterization of a novel candidate gene therapy and vaccination vector based on human species D adenovirus type 56.

Duffy MR, Alonso-Padilla J, John L, Chandra N, Khan S, Ballmann MZ, Lipiec A, Heemskerk E, Custers J, Arnberg N, Havenga M, Baker AH, Lemckert A. Duffy MR, et al. Among authors: lemckert a. J Gen Virol. 2018 Jan;99(1):135-147. doi: 10.1099/jgv.0.000978. Epub 2017 Nov 20. J Gen Virol. 2018. PMID: 29154744

10

Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity.

Lemckert AAC, Grimbergen J, Smits S, Hartkoorn E, Holterman L, Berkhout B, Barouch DH, Vogels R, Quax P, Goudsmit J, Havenga MJE. Lemckert AAC, et al. J Gen Virol. 2006 Oct;87(Pt 10):2891-2899. doi: 10.1099/vir.0.82079-0. J Gen Virol. 2006. PMID: 16963747

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

31 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year